View photo.By and large, the short interest moves in the leading biotechs and emerging pharmaceuticals were mild between the February 27 and March 13 settlement dates. However, Celgene Corporation (NASDAQ: CELG), Illumina, Inc. (NASDAQ: ILMN) and Medivation Inc (NASDAQ: MDVN) saw double-digit percentage upswings in their short interest.Here we take a quick look at how these three stocks have fared […]
Something rare is happening in the market
Jonathan Krinsky, MKM Partners, turns a technical eye on the S&P to get a read on “three black crows” and whether the negative trend will continue. And CNBC’s Courtney Reagan and the Futures Now Traders Scott Nations and Jeff Kilburg have a short trade on the S&P’s anomaly.
Stocks erased their early losses, spurring some […]
Slump in biotech and technology stocks sent benchmarks to negative territory for third straight sessions on Wednesday. These sectors witnessed intense selling pressure as investors remained concerned that strength in the U.S. dollar will negatively impact earnings growth in upcoming quarters. However, the dollar weakened yesterday against major currencies following release of dismal durable orders data. The Nasdaq witnessed its […]
Akin Oyedele
Mar. 26, 2015, 8:22 AM
253
Wikimedia CommonsSome investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains […]
Pedro Castellano | Getty ImagesInvestors are bailing on biotech stocks at such a rapid pace that it is shocking even some of the most-seasoned traders. It’s a popping bubble that could have implications on the sustainability of this six-year bull market.Consider this, the most popular ETF in the sector—the Nasdaq Biotechnology iShares (IBB)—hit an all-time intraday high Friday of $374.62. […]
Akin Oyedele
Mar. 26, 2015, 8:22 AM
1,134
Wikimedia CommonsSome investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains […]
View photo.(Wikimedia Commons)Some investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains of 3% for the […]
Pedro Castellano | Getty ImagesInvestors are bailing on biotech stocks at such a rapid pace that it is shocking even some of the most-seasoned traders. It’s a popping bubble that could have implications on the sustainability of this six-year bull market.Consider this, the most popular ETF in the sector—the Nasdaq Biotechnology iShares (IBB)—hit an all-time intraday high Friday of $374.62. […]
Stock Trading Alert: Stocks Sold Off And Retraced Last Week’s Advance, Will They Continue Down?By: Paul Rejczak | Thu, Mar 26, 2015SharePrintEmailStock Trading Alert originally published on March 26, 2015, 7:30 AM:Briefly: In our opinion, no speculative positions are justified.Our intraday outlook is now neutral, and our short-term outlook is neutral:Intraday outlook (next 24 hours): neutralShort-term outlook (next 1-2 weeks): […]
A very interesting day in the markets as the S&P 500 fell 1.46% and the NASDAQ 2.37%. Biotechs were crushed today – we’ve been saying the higher they go the more risk they get as they have been on a mostly interrupted run for 4+ years. That said you just never know when they will correct and even if it’s […]
